• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK; IN VITRO DIAGNOSTICS Back to Search Results
Catalog Number 1912997
Device Problem Low Readings (2460)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/17/2020
Event Type  malfunction  
Manufacturer Narrative
The investigation has determined that lower than expected vitros thyroid stimulating hormone (tsh) results were obtained when processing samples from four different patients using vitros immunodiagnostics products tsh reagent lot 6060 in combination with a vitros 5600 integrated system.The results were lower than expected when compared to results from a non-vitros roche system.A definitive assignable cause could not be determined for the lower than expected patient sample results.Based on historical quality control results, a vitros tsh lot 6060 performance issue is not a likely contributor to the events and there was no indication the vitros tsh reagent in use or the vitros 5600 integrated system malfunctioned in any way.However, an instrument issue cannot be entirely ruled out as a contributing factor as precision testing to assess instrument performance was not performed by the customer at the time of the event.In addition, it was not possible to establish if the customer was following the sample collection device manufacturer¿s recommendation for sample centrifugation.Therefore, improper pre-analytical sample handling could have contributed to this event.It is possible that cellular debris, due to poor sample preparation, was present in the affected samples, although this could not be confirmed.A possible cause for the lower than expected vitros tsh patient sample results is an unknown sample specific interferent present in the patient samples themselves.However, the customer failed to provide when requested, any additional testing results using appropriate blocking tubes.Therefore, the presence of an unknown sample interferent causing the lower than expected vitros tsh results cannot be completely ruled out.Additionally, it was established that patient 4 was in receipt of a list of medications for a skin condition and the medications or their metabolites cannot be ruled out as a potential cause of the lower than expected result for that patient.Continual tracking and trending of complaints has not identified any signals that would indicate a potential systematic issue with vitros tsh reagent lot 6060.
 
Event Description
A customer reported lower than expected vitros thyroid stimulating hormone (tsh) results obtained when processing samples from four different patients using vitros immunodiagnostics products tsh reagent in combination with a vitros 5600 integrated system.The results were lower than expected when compared to results from a non-vitros roche system at an alternate site.Patient 1 results of 0.412 and 0.432 miu/l (hyperthyroid) versus the expected result of 0.72 miu/l (euthyroid).Patient 2 results of 0.431 and 0.390 miu/l (hyperthyroid) versus the expected result of 0.65 miu/l (euthyroid).Patient 3 results of 0.213 and 0.208 miu/l (hyperthyroid) versus the expected result of 0.40 miu/l (euthyroid).Patient 4 result of 0.416 miu/l (hyperthyroid) versus the expected result of 2.14 miu/l (euthyroid).Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected.It is not known if the lower than expected vitros tsh results were reported from the laboratory.However, there has been no allegation of patient harm as a result of the event.This report is number two of two mdr¿s for this event.Two 3500a forms are being submitted for this event as two devices were involved.This report corresponds to ortho clinical diagnostics inc.Complaint number (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key10159524
MDR Text Key220695118
Report Number3007111389-2020-00062
Device Sequence Number1
Product Code JLW
Combination Product (y/n)N
Reporter Country CodeAE
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Reporter Occupation Other
Type of Report Initial
Report Date 06/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/16/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/03/2020
Device Catalogue Number1912997
Device Lot Number6060
Was Device Available for Evaluation? Yes
Date Manufacturer Received05/22/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/16/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-